Piramal Enterprises eyes expanding footprint in US, Europe: Report

12 Jul 2017 Evaluate

Piramal Enterprises is reportedly looking to expand its footprint in its pharma vertical in global markets such as the US, Europe and Japan. In this regards, the company is planning to introduce more products.

The company will continue to add more generic hospital products both organically and inorganically to leverage its strong sales and distribution network, integrating acquired products and generating synergies.

The company generates over 70% of its revenue from pharmaceuticals business in North America and Europe. Its pharma vertical is divided into two - the global pharma business that sells pharma products and services globally and the India consumer products business that sells OTC products in India.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 943.00
Shriram Finance 1006.35
Aditya Birla Capital 354.45
Chola Invest & Fin. 1663.30
Tata Capital 357.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×